PRINCETON, N.J. , April 21, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that it has received $1.7 million in cash proceeds from the sale of its 2023 and amended 2022 Net Operating Loss (NOL) and R&D tax credits from the Technology Business Tax Certificate Transfer Program, sponsored by the New Jersey Economic Development Authority (NJEDA).

image for news CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

NEW YORK CITY, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company") (NYSE:ATNM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Actinium securities between March 31, 2022 and August 2, 2024, both dates inclusive (the "Class Period").

image for news ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Constellation Brands, Inc. ("Constellation Brands" or "the Company") (NYSE:STZ) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Constellation Brands securities between April 11, 2024 and January 8, 2025, both dates inclusive (the "Class Period").

image for news FINAL REMINDER STZ DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Constellation Brands, Inc. Investors to Participate in the Class Action Lawsuit

NEW YORK CITY, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Everus Construction Group, Inc. ("Everus" or "the Company") (NYSE:ECG) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Everus common stock between October 31, 2024 and February 11, 2025, both dates inclusive (the "Class Period"), including investors who held MDU Resources …

image for news ECG SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Everus Construction Group, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against SoundHound AI, Inc. ("SoundHound" or "the Company") (NASDAQ:SOUN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired SoundHound securities between May 10, 2024 and March 3, 2025, both dates inclusive (the "Class Period").

image for news SOUN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that SoundHound AI, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Solaris Energy Infrastructure, Inc. ("Solaris" or "the Company") (NYSE:SEI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Solaris securities between July 9, 2024 and March 17, 2025, both dates inclusive (the "Class Period").

image for news SEI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Solaris Energy Infrastructure, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MGP Ingredients, Inc. ("MGP Ingredients" or "the Company") (NASDAQ:MGPI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired MGP Ingredients securities between May 4, 2023 and October 30, 2024, both dates inclusive (the "Class Period").

image for news MGPI Shareholders Have Opportunity to Lead MGP Ingredients, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

NEW YORK, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or "the Company") (NASDAQ:SANA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Sana securities between March 17, 2023 and November 4, 2024, both dates inclusive (the "Class Period").

image for news SANA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sana Biotechnology, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bakkt Holdings, Inc. ("Bakkt" or "the Company") (NYSE:BKKT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Bakkt securities between March 25, 2024 and March 17, 2025, both dates inclusive (the "Class Period").

image for news BKKT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bakkt Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit

Company to highlight preclinical study of ARV-393, an investigational PROTAC BCL6 degrader, in combination with standard of care therapies Company to highlight preclinical study of ARV-393, an investigational PROTAC BCL6 degrader, in combination with standard of care therapies

image for news Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting

NEW YORK, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ibotta, Inc. ("Ibotta" or "the Company") (NYSE:IBTA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ibotta securities pursuant to the registration statement and prospectus issued in connection with the Company's April 18, 2024 initial public offering ("IPO").

image for news IBTA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ibotta, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

JACKSONVILLE, Fla.--(BUSINESS WIRE)---- $RDW--Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next-generation space economy, announced today that it has launched a new drug development technology and a cancer-detection experiment to the International Space Station (ISS) as the company scales its in-space pharmaceutical drug development program based on the success of its PIL-BOX platform. To complement the existing PIL-BOX platform, Redwire is launching a high-volume Industrial.

image for news Redwire Expands In-Space Drug Development Program, Launches New PIL-BOX Technology and Cancer-Detection Experiment

NEW YORK CITY, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Canopy Growth Corporation ("Canopy" or "the Company") (NASDAQ:CGC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Canopy securities between May 30, 2024 and February 6, 2025, both dates inclusive (the "Class Period").

image for news CGC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Canopy Growth Corporation Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Edison International ("Edison" or "the Company") (NYSE:EIX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Edison securities between February 25, 2021 and February 6, 2025, both dates inclusive (the "Class Period").

image for news FINAL REMINDER EIX DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Edison International Investors to Participate in the Class Action Lawsuit

NEW YORK, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Trade Desk, Inc. ("Trade Desk" or "the Company") (NASDAQ:TTD) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Trade Desk securities between May 9, 2024 and February 12, 2025, both dates inclusive (the "Class Period").

image for news FINAL REMINDER TTD DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts The Trade Desk, Inc. Investors to Participate in the Class Action Lawsuit

NEW YORK, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against e.l.f. Beauty, Inc. ("Elf" or "the Company") (NYSE:ELF) and certain of its officers.

image for news ELF SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that e.l.f. Beauty, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

GPIQ Vs. QDTE: Both Option ETFs Have Unique Benefits — Neutral

GPIQ  QDTE   Seeking Alpha — April 21, 2025

Option ETFs can harness market volatility for high distribution income, with GPIQ and QDTE offering different strengths for investors. GPIQ holds underlying equities and uses a dynamic option strategy, providing better price stability and capital preservation. QDTE's synthetic strategy offers a higher dividend yield but lacks downside protection, leading to potential price erosion.

image for news GPIQ Vs. QDTE: Both Option ETFs Have Unique Benefits

Apellis Announces Craig Wheeler to Join the Board of Directors — Neutral

APLS   GlobeNewsWire — April 21, 2025

WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the Apellis Board of Directors, effective immediately. Mr. Wheeler is a highly accomplished executive with more than 30 years of leadership experience across the biopharmaceutical industry.

image for news Apellis Announces Craig Wheeler to Join the Board of Directors

BioCryst to Report First Quarter 2025 Financial Results on May 5 — Neutral

BCRX   GlobeNewsWire — April 21, 2025

RESEARCH TRIANGLE PARK, N.C., April 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2025 financial results on Monday, May 5, 2025.

image for news BioCryst to Report First Quarter 2025 Financial Results on May 5

NEW YORK , April 21, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: SANA) between March 17, 2023 and November 4, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2025 lead plaintiff deadline. So what: If you purchased Sana securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit